Three-Month Mortality in Nonhaematological Patients with Chronic Pulmonary Aspergillosis: Differences between Subtypes
Authors:
- Pablo González GarcíaPGPablo González García
- Julia Fernández-NavarroJFJulia Fernández-Navarro
- Mónica Bru-ArcaMBMónica Bru-Arca
- Elisa Álvarez-ArteroEÁElisa Álvarez-Artero
- Pablo SolísPSPablo Solís
- María Pía Roiz MesonesMMMaría Pía Roiz Mesones
- Juan Luis Muñoz BellidoJBJuan Luis Muñoz Bellido
- María Antonia García CastroMCMaría Antonia García Castro
- Moncef Belhassen-GarcíaMBMoncef Belhassen-García
- Javier Pardo LledíasJLJavier Pardo Lledías
Open Access
- 10 October 2024
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (10) , 706
Abstract
Objectives: Chronic pulmonary aspergillosis (CPA) is a fungal lung infection characterised by the slowly progressing destruction of the lung parenchyma and has four main subtypes. The objective of this work was to evaluate the epidemiology of CPA in our area and evaluate the involvement of the different subtypes in mortality. Methods: This was a descriptive longitudinal retrospective study developed in three tertiary hospitals in Spain. Among all patients admitted with a pulmonary aspergillosis diagnosis, we selected those who fulfilled the criteria for chronic aspergillosis according to the criteria of Denning, excluding those with a haematological disorder. Results: Among 409 inpatients recorded as having a pulmonary aspergillosis infection, only 76 (18.5%) fulfilled the criteria for CPA, with an estimated incidence of 0.67 cases/100,000 inhabitants/year. The subtypes detected were subacute invasive aspergillosis (SAIA) in 33 (43.4%) patients, simple aspergilloma (SA) in 25 (32.9%) patients, cavitary chronic aspergillosis (CCPA) in 13 (17.1%) patients, and chronic fibrosis (CFPA) in five (6.5%) patients. The overall three-month mortality rate was 23%, which was higher in SAIA patients. The predictors of early mortality were age > 65 years (OR 3.0 CI 95 1.0–9.5 p = 0.043) and the SAIA subtype vs. other subtypes (OR 3.1 CI 95 1.0–9.5 p = 0.042). Conclusions: The incidence rate estimated was inferior to that previously reported. The three-month mortality in patients with CPA was high, with older age and the SAIA subtype being the variable independent predictors of a worse prognosis.Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018Open Forum Infectious Diseases, 2022
- Epidemiology of aspergillosis in hospitalised Spanish patients—A 21‐year retrospective studyMycoses, 2021
- Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational studyMycoses, 2019
- The spectrum of pulmonary aspergillosisRespiratory Medicine, 2018
- European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in LeukaemiaJournal of Antimicrobial Chemotherapy, 2018
- Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patientsMedicine, 2017
- A 10-year study reveals clinical and laboratory evidence for the ‘semi-invasive’ properties of chronic pulmonary aspergillosisEmerging Microbes & Infections, 2016
- Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registryThe Clinical Respiratory Journal, 2014
- Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trialEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 casesInternational Journal of Infectious Diseases, 2010